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ABSTRACT  
 
Background: Brazil has a high prevalence of infections caused by different arboviruses. The 
standard method used for diagnosis is an Enzyme-linked immunosorbent assay for IgM capture 
(MAC-ELISA). This study aimed to optimize and evaluate a one-step reverse transcription-
polymerase chain reaction to detect acute infections caused by dengue, zika, chikungunya, and 
mayaro virus in clinical samples. Methods: We evaluated 620 sera samples collected from 
March 2016 to March 2018 and provided by the Central Health Laboratory of Maranhão 
(LACEN-MA). Total RNA was isolated from clinical specimens and used as the template for 
one-step RT-PCR assays with specific-primers designed for this study. Results: Of the 620 
sera evaluated, 386 (62.2%) were positive, among them 330 (85.5%) amplified a specific 
fragment for chikungunya, 55 (14.2%) showed a fragment compatible with dengue serotype 4, 
and 1 (0.3%) exhibited profile for mayaro virus. Conclusions: The results obtained here were 
more sensitive than IgM-ELISA because the viral RNA was detected in serum samples from 
patients, not only from 1 to 6 days but also from 7 to 10 days after the beginning of clinical 
signs (convalescent period). Besides, the mayaro virus was detected in one serum sample that 
was IgM-ELISA negative for dengue, zika, and chikungunya. 
 
Keywords: Chikungunya virus; Zika virus; Mayaro virus 
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RESUMO 
 
Antecedentes: O Brasil tem uma alta prevalência de infecções causadas por diferentes 
arbovírus. O método padrão usado para o diagnóstico é um ensaio imunossorvente ligado à 
enzima para captura de IgM (MAC-ELISA). Este estudo teve como objetivo otimizar e avaliar 
uma reação em cadeia da polimerase com transcrição reversa em uma etapa para detectar 
infecções agudas causadas pelo vírus da dengue, zika, chikungunya e mayaro em amostras 
clínicas. Métodos: Avaliamos 620 amostras de soro coletadas de março de 2016 a março de 
2018 e fornecidas pelo Laboratório Central de Saúde do Maranhão (LACEN-MA). O RNA 
total foi isolado a partir de amostras clínicas e utilizado como modelo para ensaios de RT-PCR 
em uma etapa com iniciadores específicos projetados para este estudo. Resultados: Dos 620 
soros avaliados, 386 (62,2%) foram positivos, dentre eles 330 (85,5%) amplificaram um 
fragmento específico para chikungunya, 55 (14,2%) apresentaram fragmento compatível com 
o sorotipo 4 da dengue e 1 (0,3%) exibiu perfil para o vírus mayaro. Conclusões: Os resultados 
aqui obtidos foram mais sensíveis que o IgM-ELISA, pois o RNA viral foi detectado em 
amostras de soro de pacientes, não apenas de 1 a 6 dias, mas também de 7 a 10 dias após o 
início dos sinais clínicos (período de convalescença). Além disso, o vírus mayaro foi detectado 
em uma amostra de soro negativa para IgM-ELISA para dengue, zika e chikungunya. 
 
Palavras-chave: vírus Chikungunya; Vírus zika; Vírus Mayaro. 
 
1. INTRODUCTION 
 The arboviruses are a heterogeneous group of viruses that are transmitted to humans via 
the bite of arthropod vectors, especially mosquitoes [1,2]. The female of the Aedes aegypti is 
the primary vector of the dengue virus (DENV), Zika (ZIKV), and chikungunya (CHIKV) 
[3,4,5]. These mosquitoes have a diurnal activity and peridomestic habits; it's depositing their 
eggs preferentially in containers of water [6]. These eggs are resistant to dissection, and this 
property allows them to withstand unfavorable environmental conditions [7]. 
 In Brazil, several arboviruses have been detected in the last years, among which DENV, 
CHIKV, ZIKV, Yellow Fever virus (YFV), and mayaro virus (MAYV) [8]. DENV, ZIKV, and 
YFV belong to the Flaviviridae family and genus Flavivirus, whereas CHIKV and MAYV are 
members of the Togaviridae family and genus Alphavirus [6,9]. The clinical signs and 
symptoms caused by these arboviruses are very similar, making it difficult to diagnose these 
infections [10,11] accurately. 
 Dengue human infections are caused by four genetically and antigenically distinct 
serotypes, DENV-1 to DENV-4, each generating a unique host immune response to infection 
[12,13]. The occurrence of DENV cases in the American continent in recent years has exceeded 
2 million cases per year. The increase in the number of DENV infections, including severe 
cases and deaths, has been growing significantly and is becoming alarming [14]. In Brazil, 
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3,659,093 cases of DENV were reported, with 2,089 deaths occurring from 2015 to 2018 
[14,15,16,17,18]. 
 Historically, the first case of CHIKV infection occurred in Uganda in 1947; since then, 
the number of diseases has been growing and expanding worldwide since 2004 [19]. However, 
the first outbreak was only confirmed in 2007 in Micronesia. There been an increase in the 
transmission area since then, expanding to islands in the Pacific Ocean and Polynesia [20,21]. 
At the same time, alterations in the envelope protein (E1) of the African viral lineage and 
adaptation processes gave A. albopictus a higher capacity of infection; this increased the 
number of cases. These mutations increased the epidemic risk relative to other tropical, 
subtropical, and temperate regions [22]. 
 In Brazil, the first autochthonous case of CHIKV infection was reported in September 
2014 [23], and since then, it has been responsible for periodic outbreaks in all Brazilian states. 
Epidemiological reports of CHIKV cases issued by the Ministry of Health from 2015 to 2018 
presented a total of 583,901 cases and 383 deaths [14,15,16,17,18]. 
The entry of ZIKV to Brazil occurred in 2015 with confirmed cases in the state of Bahia [24]. 
It subsequently spread to other regions, like Rio de Janeiro, São Paulo, and Pernambuco, where 
patients experienced exanthematic fever [25]. Since the introduction of ZIKV in Brazil in 2015, 
the Ministry of Health recorded a total of 241,191 confirmed cases and more than 300 deaths 
[14,15,16,17,18]. 
 Mayaro virus (MAYV) is another arbovirus in an emergency in Brazil. It is transmitted 
by Haemagogus spp., mosquitoes, especially the species Haemagogus janthinomys, which is 
the primary known vector [26,27]. This vector maintains a wild cycle, and it can be found in 
the treetops, the primates that move from tree to tree are stung by these mosquitoes, becoming 
natural reservoirs of this virus [28, 29, 30].   
 The first report of MAYV isolation occurred in 1954 in Trinidad and Tobago, where it 
was found in the blood of five rural workers who had been clinical characteristics of arbovirus 
infection. Since then, endemic outbreaks have been recorded in Bolivia, Brazil, French Guiana, 
Guyana, and Suriname [31]. MAYV is considered endemic in some Brazilian regions (North 
and Central West). The first isolation in the country occurred in 1955 in the state of Pará. Since 
then, sporadic cases of MAYV have been reported in this region [32]. 
 The diagnosis of these arboviruses is based on three main laboratory methods: virus 
isolation, serological tests, including the plaque reduction neutralization test (PRNT), enzyme-
linked immunosorbent assay (ELISA), and immunofluorescence test (IFT) [33]. Besides, the 
BrazilianJournal of Development 
 
  Braz. J. of  Develop., Curitiba,  v. 5, n. 9, p. 16620-16644  sep. 2019      ISSN 2525-8761 
 
16624  
reverse transcription reaction followed by polymerase chain reaction (RT-PCR) technique has 
been widely used [33]. Viral isolation is time-consuming, and it is limited by the high cost and 
training requirements [34]. PRNT uses paired samples and presents cross-reactivity among 
members of the flavivirus group, and this method can present a cross-reaction with other 
serotypes in the case of a secondary DENV infection [35]. 
 The serological diagnosis is confirmed by direct detection of IgM antibodies or by 
determination of a four-fold increase in specific antibodies titers in acute and convalescent 
samples using ELISA, IFT, or PRNT tests [33]. PCR-based assays are suitable for clinical 
diagnosis because of the closed-tube assay format and high sensitivity and specificity [33]. 
 The arboviruses DENV, CHIKV, and ZIKV [36], and MAYV are currently co-
circulating in Brazil. The increase in the number of people infected by arboviruses and the 
increased morbimortality rate is related to the lack of an effective vaccine, specific treatments, 
lack of planning to control and prevent the vectors responsible for transmitting the viruses [16]. 
This study aimed to evaluate molecular assays to diagnose arbovirus infections in serum 
samples from patients with clinical signs suggesting acute infection. 
 
2. MATERIALS AND METHODS 
 
2.1 CLINICAL SERA SAMPLES AND SOCIODEMOGRAPHIC DATA 
 For this study, 620 serum samples were randomly selected from the Central Laboratory 
of Public Health of the State of Maranhão (LACEN-MA) serum bank. These samples were 
from patients who sought public health services from March 2016 to March 2018. Of the 620 
serum samples, 351 (56.6%) were from patients from 1 to 6 days after onset of signs and 
symptoms suggesting arbovirus infection, and 269 (43.4%) sera were 7 to 10 days after 
infection. 
 All these samples had been previously screened by LACEN technicians to detect IgM 
antibodies against DENV, CHIKV, and ZIKV. The following diagnostic kits were used to 
detect antibodies against these arboviruses: DENV ELISA IgM kit (PANBIO, Brisbane, 
Australia), anti-CHIKV (IgM) ELISA Kit (EUROIMMUN, LÜBECK, GERMANY), and 
ZIKV anti-ZIKV ELISA kit IgM and IgG (EUROIMMUN, LÜBECK, GERMANY). 
According to the data collected in the Laboratory Management System (GAL) of LACEN-
MA, 536 (86.5%) sera were IgM-ELISA positive, and 84 (13.5%) were negative. 
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The sociodemographic data of each patient were collected in the GAL system, but in this 
database no clinical data on the patients were found, only age, sex, ethnicity and period of 
infection, including the date of the beginning of the clinical signs and symptoms until the day 
the patient sought the Basic Health Unit (UBS). 
 
2.2 ARBOVIRAL LINEAGES USED AS A POSITIVE CONTROL 
 Aliquots of the culture medium of the dengue reference strains (DENV-1, Hawaii, 
DENV-2, ThNH7/93, DENV-3, PhMH-J1-97, and DENV- 4, SLMC 318), CHIKV (S27-
African), ZIKV (BeH819966), and MAYV (BeAr20290) were kindly provided by the 
Department of Arboviroses of the University of São Paulo (USP)/School of the Medicine of 
Ribeirão Preto. As a negative control, we used 30 aliquots of sera from individuals who had 
never had any of the arboviruses screened. These samples are part of our private sera collection. 
 
2.3 ISOLATION OF MAYARO VIRUS 
 For the isolation of  MAYV, we used the Vero cell line (ATCC CCL-81) originating 
from African green monkey kidneys in Dulbecco's modified Eagle's medium (DMEM) 
supplemented with Earle's salts, L-glutamine (SIGMA-ALDRICH PRODUCTS, USA), and 
supplemented with 10% fetal bovine serum (FBS), 1 % antibiotic/antimycotic solution (10,000 
units/mL penicillin, 10,000 μg/mL streptomycin, and 25 μg/mL amphotericin B) (Gibco-
BioSciences, Ireland). Incubation of the culture in an atmosphere containing 5% CO2 at 37 °C 
was monitored until 80% confluency. An aliquot of 10 ul of the patient's serum was inoculated 
in the culture bottle with 1 mL of DMEM medium with 2% FBS plus antibiotics, then was 
incubated for one hour until adsorption of the viral particle. The medium was removed, and 4 
ml of the same medium was added; the culture bottle was incubated under the same conditions. 
The cytopathic effect was monitored until total lysis of the cell monolayer. Aliquots of up to 5 
passages were stored at -80 °C in cryotubes containing SFB plus 2% of dimethylsulfoxide 
(DMSO; MERCK, GERMANY). 
 
2.4 RNA EXTRACTION AND MOLECULAR ASSAYS 
 To obtain the total RNA for the molecular assays, we used the QIAMP RNA VIRAL 
Kit (QIAGEN, HILDEN, GERMANY) according to the manufacturer's instructions. The total 
viral RNA was quantified using NanoDrop (THERMO SCIENTIFIC, WALTHAM, 
MASSACHUSETTS, USA) and stored at -80 °C until use. 
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The primers used to amplify the genetic material of DENV, CHIKV, and MAYV were designed 
from the non-structural protein NSP1, whereas the ZIKV primers started at the end of the 
envelope glycoprotein until at the end of the dimerization domain II. To optimize the one-step 
RT-PCR conditions for each pair of primers was used as the template RNA from the reference 
strains DENV (1 to 4), CHIKV, ZIKV, and MAY. The sequences of all primers used and 
conditions of the amplification for each arbovirus are described in Table 1. 
 The initial trials of one-step RT-PCR were made to amplify the four DENV serotypes 
individually. Each reaction had a final volume of 50 µl, containing 10 picomoles of each pair, 
plus OneStep RT-PCR Enzyme Mix (1×), 5x QIAGEN OneStep RT-PCR Buffer (1×), dNTP 
Mix (10 mM each), 5× Q-Solution (1×), RNase-Free Water (1×) (QIAGEN, HILDEN, 
GERMANY), and 100 nanograms of RNA from the reference serotype as template. The 
amplification occurred under the following conditions: one initial cycle of 50 ºC for 30 minutes, 
denaturation at 94 ºC for 15 minutes, 35 cycles of 94 ºC for 1 minute, annealing at 56 ºC for 1 
minute, extension at 72 °C for 2 minutes and final extension at 72 °C for 10 minutes. 
 After the optimization with each pair of primers, the one-step RT-PCR was used to 
detect the DENV serotypes in clinical samples. We used the same conditions of amplification 
to amplify RNA from reference strains CHIKV, ZIKV, and MAYV. However, the temperature 
of the primers that were specific for each of these arboviruses (Table 1). 
 Finally, after the optimization process, the same one-step RT-PCR conditions were used 
to detect the presence of CHIKV, ZIKV, and MAYV viral RNA in the serum samples of 
patients with clinical suspicion of infection. 
 
2.4.1 One-step rt-pcr sensitivity and pecificity 
 The sensitivity of the one-step RT-PCR assays was verified with a serial dilution of 100 
nanograms of the total CHIKV reference lineage RNA. This RNA was previously quantified 
in the NanoDrop Thermo Scientific NanoDrop 2000 spectrophotometer (Thermo Fisher 
Scientific, Waltham, MA, USA). Serial dilution was started from 100 ng RNA as follows 1: 2 
(50 ng); 1: 4 (25 ng); 1: 8 (12.5 ng); 1:16 (6.25 ng); 1: 32 (3.12 ng) and 1:64 (1.56 ng). For the 
reaction, a final volume of 50 μL consisting of specific reagents from the QIAGEN OneStep 
RT-PCR kit was used as described above with 10 picomoles of each pair of primers. The 
reaction tubes had a decreasing template input amount: 50 ng, 25 ng, 12.5 ng, 6.25 ng, 3.12 ng, 
and 1.56 ng. Amplification conditions were the same as those described above, but with a 
specific melting temperature of the primers for CHIKV (Table 1). 
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The specificity of the primers designed exclusively for this study was verified with 100 ng of 
the total RNA extracted from the yellow fever virus (YFV), and Saint Louis Encephalitis virus 
(SLEV). Amplification reactions were performed using the same conditions described above, 
with the specific temperature of each primer pair (Table 1). 
 
2.4.2 Electrophoretic analysis of one-step rt-pcr products 
 All results obtained by the molecular method were verified on a 2% agarose gel 
electrophoresis; thus it was used 8 µL of each amplified product, plus 2 µL of sample buffer 
(Blue Orange 6× Loading Dye-PROMEGA, USA), and electrophoresis was performed as 
previously described [37]. The run occurred in 0.5× TBE buffer (Tris-borate-EDTA) (100 mM 
Tris-base; 2.0 mM EDTA solution (pH 8.0) and 50 mM boric acid) (PROMEGA, USA) at 85 
V for 1 hour and 30 minutes. After the electrophoresis, the gels were stained in ethidium 
bromide solution (0.5 μg / mL) for 15 minutes, and observed using an ultraviolet 
transilluminator, and photographed to document the results. 
 
2.4.3 One-step rt-pcr product purification, sequencing, and sequence analysis 
 To sequence the product of one-step RT-PCR it was used the Wizard® SV Gel and 
PCR Clean-Up kit, according to the manufacturer's guidelines (PROMEGA, USA). The 
sequencing was perforrmed with the DyEnamic ™ kit ET Dye Terminator in a MegaBaceTM 
1000 automatic sequencer (Amersham Biosciences), according to a previously described 
method [38]. 
 The ChromasPro program (Technelysium Pty. Ltd - 
http://www.technelysium.com.au/chromas.html) was used to analyze the electropherograms 
provided by MegaBace during the sequencing process. To check the similarity of the obtained 
sequences, we used the program BLASTn in the package BLAST 2.0 (Basic Alignment Search 
Tool - http://www.ncbi.nlm.nih.gov/BLAST/) [39]. The MEGA software version 6 [40] was 
used to align the sequences obtained with MAYV sequencing in Genbank. 
 
2.5 STATISTICAL ANALYSIS 
 The sociodemographic data collected in the GAL system of each patient selected were 
tabulated in an Excel spreadsheet and analyzed by statistical program IBM SPSS Statistics 25.0 
[41] and R Commander [42]. The descriptive statistic analysis  (minimum, maximum, mean, 
and standard deviation) was applied to analyze numerical variables (age and days) concerning 
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gender. The evaluation of the association of the sociodemographic variables and the day of 
onset of signs and symptoms about the results of ELISA-IgM and one step-RT-PCR assays 
were performed using the parametric Chi-square independence test. The level of significance 
of the tests was 5% or a p-value of <0.05 and a 95% confidence interval. 
 
2.6 ETHICS STATEMENT 
 The present study was submitted to the Research Ethics Committee of the Universidade 
Ceuma, and it was approved under a consubstantiated opinion number: 1,570,391/2016, 
emitted on 12 May 2016. 
 
3. RESULTS 
 
3.1 OPTIMIZATION OF ONE-STEP RT-PCR ASSAY WITH RNA FROM REFERENCE 
STRAINS 
 In this study, we report the evaluation of a one-step RT-PCR assay for the diagnosis or 
detection of arbovirus infections. We used 620 sera samples that had been previously screened 
by ELISA for the detection of IgM antibodies against DENV, ZIKV, and CHIKV. The results 
of IgM ELISA assays showed that 536 (86.5%) sera were positive, and 84 (13.5%) were 
negative. Of these, 498 (49.1%) were positive for CHIKV, and 38 were positive for DENV, 
and none of the samples evaluated by ELISA were reactive to ZIKV. 
 Initially, it was optimized and evaluated the one-step RT-PCR assays with RNA from 
reference strains. Specific fragments with the expected molecular size, for each of the 
arboviruses screened, were viewed on agarose gels (Figure 1), being 1A: profiles of CHIKV; 
1B: ZIKV; 1C: MAYV and DENV serotypes (1-4). 
 
3.1.1 Evaluation of one-step rt-pcr assays with rna obtained from clinical samples 
 Of the 620 samples evaluated by one-step RT-PCR assays, a total of 386 (62.2%) were 
positive for arboviruses, CHIKV, DENV, and MAYV. Of these, 78.0% (301) were 
serologically positive, and 22.0% (85) were IgM ELISA negative by anti-CHIKV (IgM) 
ELISA Kit (EUROIMMUN). Of the positive IgMs, 89.7% (270) were from patients who were 
in the acute phase of infection, and 31 (10.3%) were in the convalescent period. Regarding the 
serum IgM negative samples, 81 (95.3%) were in the acute phase, and 4 (4.7%) in the 
convalescent phase (Table 2). 
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 Of the 386 positive samples by one-step RT-PCR, 330 (85.5%) were positive for 
CHIKV based on the amplification of the specific 623 bp fragment, as shown in Figure 2. It is 
interesting to note that, out the 330 serum samples, 67 (20.3%) were negative in the IgM 
ELISA. These sera were from patients who sought health services within a period of 1 to 8 
days after the onset of signs and symptoms. The remaining 263 sera were from patients who 
went to hospitals from the first to the tenth day after the beginning of clinical signs and 
symptoms. These sera samples were positive by the IgM ELISA anti-CHIKV (IgM) ELISA 
Kit (EUROIMMUN) test (Table 2). 
 The one-step RT-PCR assay detected 55 (14.2%) serum as DENV positive with the 
profile for serotype 4 based on the presence of the specific of 434 bp fragment, as shown in 
Figure 3. Of the DENV positive samples, 17 (30,9%) were serologically negative using the 
DENV ELISA IgM kit (PANBIO). These serum samples were from patients from 1 to 3 days 
after the onset of clinical signs and symptoms suggesting DENV infection. The other 38 sera 
samples were from 1 to 7 days after onset of the disease were ELISA positive. 
It is important to note that a serum sample that had been tested with different IgM ELISA kits 
for the detection of antibodies against dengue, zika, and chikungunya arboviruses was always 
negative. This RNA was submitted for one-step RT-PCR to detect DENV, CHIKV, and ZIKV, 
but no amplification was observed. However, when specific primers for MAYV were used in 
one-step RT-PCR, the specific 370 bp fragment was amplified (Figure 4). This result triggered 
the isolation of MAYV from the patient's serum sample. The one-step RT-PCR product was 
purified and sequenced, and its sequence was deposited in GenBank with the accession number 
MK956954. 
 The presence of the ZIKV genetic material was not detected in any of the clinical 
samples evaluated in this study. However, the amplification of the RNA from reference viral 
strain occurred in all one-step RT-PCR assays (Figure 5). 
 
3.1.2 Sensitivity and pecificity of the primers and one-step RT-PCR assays 
 The sensitivity of the one-step RT-PCR was performed using a serial dilutions of the 
RNA of CHIKV reference lineage showed amplification for the following dilutions: 1:2 (50 
ng), 1:4 (25 ng), 1:8 (12.5 ng), 1:16 (6.25 ng), and 1:32 (3.12 ng). Thus, we verified a detection 
limit of 3.12 ng of viral RNA (Figure 6). The same limit of detection was observed for DENV, 
ZIKV, and MAYV (data no shown). Moreover, the primers evaluated here were specific 
because it did not amplify YFV and SLEV RNA. 
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4. DISCUSSION 
Brazil has been considered as a hyperendemic area for the occurrence of arboviral infections 
[43]. Regarding the high number of cases of arbovirus infections that have been diagnosed by 
the ELISA method, the current rates are not known. This is because, in endemic areas, as is 
here, the vast majority of the population has secondary antibodies that hinder the serological 
diagnosis [44]. Besides, the correct diagnosis of an arbovirus infection is not restricted to the 
use of only one technique, but the differential diagnosis is essential for effective patient 
management, clinical care, and epidemiologic surveillance [45]. 
Molecular methods have emerged as an alternative tool for the use of serological tests 
commonly used for the diagnosis of infections caused by arboviruses. Currently, numerous 
PCR-based assays have been evaluated, and the results have been promising [46,47]. 
The one-step RT-PCR evaluated in the present study detected arboviruses in both acute and 
convalescent-phase (IgM positive) and negative sera by IgM ELISA from both phases. These 
findings are significant, as positive cases are no reported to the epidemiological surveillance 
services. This result is in agreement with the findings of Fortuna et al. [48] who detected the 
presence of viral RNA in both IgM ELISA positive and negative IgM sera using specific probes 
with qPCR, additionally revealing that is possible to have IgM antibodies in the acute-phase 
due to a previous infection. 
The results of the detection and amplification of viral RNA obtained from the clinical 
samples showed a high prevalence of arbovirus infections, in the state of Maranhao. CHIKV 
infections were detected in 85.5% of the positive samples by one-step RT-PCR assays. The 
state of Maranhão has a hot and humid tropical climate, which favors the proliferation of 
mosquitoes A. aegypti, with an index of infestation in at least 73.3% of its municipalities [16, 
49]. It is interesting to note that the successive outbreaks of CHIKV occurring in various parts 
of the world and may cause specific adaptive genetic changes that allow the Mosquito A. 
aegypti to contract the infection and transmit it to humans [50-52]. 
The high index of CHIKV infection observed here, showed the imminent risk of an 
expansion of new outbreaks. This result agrees with that observed by Wahid et al. [53] as, after 
the introduction of CHIKV into a new geographical site, high incidence rates occur because of 
the rapid spread. Moreover, Costa-da-Silva et al. [54] detected for the first time, a natural A. 
aegypti infection by the CHIKV genotype East-Central South African (ECSA) in the Northeast 
region, and they considered this species a vector capable of transmitting this arbovirus in urban 
areas in the region. 
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Regarding infections caused by DENV, only the serotype 4 was detected, and no other 
Dengue serotype was found. This fact is important since DENV-4 was introduced in the state 
of Maranhao at the end of 2011 [18]. As a result, when a new variant is introduced at a specific 
site, and the prevalence of this lineage overlaps with the circulating variants, demonstrating its 
potential for dispersion [55]. The theory of sequential infection by DENV is characterized by 
pre-existing antibody-dependent immuno-amplification and has been widely accepted [56]. 
Sanchez-Carbonel et al. [57] and Fortuna et al. [48] evaluated a one-step RT real-time PCR 
(qPCR) assays using a specific Taqman probe for DENV detection. This technique differs from 
our methodology because the construction of probes and the application of qPCR are expensive 
and require skilled labor. The methodology evaluated here costs less, and it is faster and does 
not demand specialized personnel. 
The detection of MAYV by one-step RT-PCR in a clinical sample is important because by 
serology were not detected antibodies against DENV, CHIKV, and ZIKV. Regarding the 
occurrence of an autochthonous case of MAYV fever caused by the infection probably 
occurred through a bite of A. aegypti, and an experimental study showed that the transmission 
of MAYV by this vector is possible [58]. 
The presence of MAYV raises an alert for the public health services from Brazil, especially 
of the state of Maranhão, as there are no reports of its presence in any state of the Northeast 
region. However, it has sporadically circulated in the North and Central West states [18]. Zuchi 
et al. [59] detected by nested-PCR the MAYV circulating in Mato Grosso during an outbreak 
of DENV. These results show the need for molecular screening of this arbovirus in patients 
with suspected dengue infection, where this virus may silently circulate. 
Most of the primers evaluated here were designed from the NS1 protein because there are 
found specific markers for the diagnosis of the infections by DENV, CHIKV, and MAYV [60]. 
However, for the specific primers for ZIKV was used a preserved region of the glycoprotein E 
(env), this region is responsible for the neutralization of human antibodies by the occurrence 
of viral infection [61]. 
The results of the sensitivity and specificity obtained by one-step RT-PCR assays were 
significant due to the use of these specific-primers sets. The literature does not report any direct 
sensitivity technique for DENV infections. While that, previous results refer to sensitivity using 
other methods such as nested-PCR with dot blot [62]; real-time PCR with the use of specific 
probes [63]; and the hybridization [64]. 
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The frequency of the distribution of the sociodemographic variables from the 386 positive 
patients evaluated here, for arbovirus infections in the molecular test, showed that 296 (76.7%) 
were female. A total of 35.7% were 16 to 30 years old (Table 3). Studies from Anker et al. 
[65], Mishra et al. [66], and Wangdi et al. [67] have demonstrated that these arboviruses affect 
younger and female people. While Kalayanarooj et al. [68] reported that this is due to the 
peridomicilliary habit of the vector, and its proliferation is often related to the accumulation of 
water in containers placed inside or around the house. Then, as women and children commonly 
stay at home longer, they to become more susceptible to mosquito bites. 
 
5. CONCLUSIONS 
In this study, we have described the first detection and molecular identification of MAYV 
in the Northeast of Brazil, especially in the state of Maranhão. Besides, we found a high 
prevalence of CHIKV infection and a decrease in dengue cases during the study period. The 
one-step RT-PCR assay evaluated herein detected the RNA from different arboviruses in IgM-
positive and IgM-negative ELISA sera samples. It was sensitive, specific, and could diagnose 
the presence of the viral RNA in sera samples from patients, both in the acute and convalescent 
phases of infection. Moreover, the optimized and evaluated method was reproducible in all 
trials and demonstrated that CHIKV, DENV, and MAYV are co-circulating in patients from 
different municipalities of the state of Maranhão. Therefore, the simultaneous circulation of 
these arboviruses and the increased incidence of infected individuals demonstrated the need for 
more effective preventive measures and faster and more sensitive diagnostic tests that could 
expedite clinical care for the patient. 
 
Author Contributions: JPPN, BOM and MFCM extracted the RNA from the serum samples 
and did molecular biology assays. SGM and VSSA performed the statistical analyzes of the 
results. LMSSC and CMFSP randomly selected the records of patients with clinical suspicion 
of arbovirus infection in the LACEN-MA database. LMSS separated the serum samples in the 
freezers -80 ºC stored in the LACEN-MA. RJGT and ASM prepared excel spreadsheets for the 
analysis of the results. MRQB designed and conducted the study, analyzed the data and drafted 
the manuscript. In addition to the activities already mentioned, all authors participated in the 
analyzes of the results and the writing of the manuscript. 
BrazilianJournal of Development 
 
  Braz. J. of  Develop., Curitiba,  v. 5, n. 9, p. 16620-16644  sep. 2019      ISSN 2525-8761 
 
16633  
Funding: The authors thank the Fundação de Amparo à Pesquisa e Desenvolvimento 
Científico do Maranhão (FAPEMA) for the financial support of the research from project 
number: PPSUS-05970/2016. 
Acknowledgments: The authors thank Dr. Eurico de Arruda Neto and Maria Lucia Silva for 
supplying the reference strains of the researched arboviruses used as positive control for 
molecular assays. We thank technical staff from LACEN-MA who performed the ELISA in 
the serum samples. We would like to thank Editage (www.editage.com) for English language 
editing. 
Conflicts of Interest: The authors declare no conflict of interest. The funders had no role in 
the design of the study; in the collection, analyses, or interpretation of data; in the writing of 
the manuscript, or in the decision to publish the results. 
 
Figure 1. Electrophoretic profiles obtained in the optimization of one-step RT-PCR for CHIKV, ZIKV, MAYV, 
and DENV using as a template the RNA from reference lineages 
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Caption: 2% agarose gel stained with ethidium bromide showing the profiles obtained with total RNA from 
reference arbovirus A: CHIKV 623 pb; B: ZIKV 911 pb; C: MAYV 370 bp and D: DENV-1 518 bp; DENV-2 
595 bp; DENV-3 372 bp; DENV-4 434bp; MM - molecular marker (100 bp DNA ladder, Promega, USA) and CN 
negative controls. Vz – empty line. 
 
Figure 2. Specific profile for chikungunya virus obtained by one-step RT-PCR assay using as a template the RNA 
extracted from some sera samples 
 
 
 
 
 
 
Caption: 2% agarose gel stained with ethidium bromide. MM - molecular marker (100 bp DNA ladder, Promega, 
USA). CN negative controls. Lines 1 to 12, the profile of the 623 bp fragment compatible with CHIKV, and line 
13-CHIKV reference sample used as a positive control during the amplification process. 
Figure 3. Electrophoretic profiles obtained by the one-step RT-PCR assays using as a template the RNA obtained 
from the sera samples of patients with clinical signs and symptoms of arbovirus infection 
 
 
 
 
 
 
 
Caption: 2% agarose gel stained with ethidium bromide. MM molecular marker (100 bp DNA ladder, Promega, 
USA). Lines 1 to 7, PCR products of some clinical samples showing amplification profiles for DENV -4. Line 8, 
CP positive control of the serotype 4 reference (434 bp), and CN negative control. 
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Figure 4. Profiles of the one-step RT-PCR assays obtained with the RNA extracted from the MAYV reference 
lineage and the serum of the patient with clinical signs and symptoms suggesting arbovirus infection 
 
 
 
 
 
 
 
Caption: 2% agarose gel stained with ethidium bromide showing the specific fragment of 370 bp obtained with 
the positive control, and with the sample (OSSD1) from the patient with clinical suspicion of arbovirus infection. 
This sample was negative by IgM-ELISA for the detection of DENV, CHIKV, and ZIKV antibodies. MM-
molecular marker (100 bp DNA ladder, Promega, USA), CN, negative control. 
Figure 5. Profiles of the one-step RT-PCR assays obtained with the RNA extracted from reference ZIKV lineage 
and the sera sample of patients with clinical signs and symptoms suggesting arbovirus infection 
 
 
 
 
 
 
Caption: 2% agarose gel stained with ethidium bromide showing the specific fragment of 911 bp obtained with 
the ZIKV positive control reference lineage. Lines 1 to 14: Profiles of the sera samples evaluated for detection of 
this arbovirus. MM. Molecular marker (100 bp DNA ladder, Promega, USA); CN, Negative control of the reagents 
used in the reaction. 
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Table 1. Primers used in the present study 
 
 
Arboviruses 
 
Primers sequence (5’ – 3’) 
 
Size in base 
pairs (pb) 
 
Melting 
temperature * 
Dengue 1 FW: CACCGGCTAATGTCAGCTGC                                               
RV: CCTGCAGAGACCATTGACTTA 
518  
 
56 
Dengue 2 FW:AGGAATCATGCAGGCAGGAA          
RV:TCCACAGTCCTCAGTCACCAC 
595 
Dengue 3 FW:CATAATAGACGGACCAAACACAC 
RV:TGTGGTTGTGTTGCGAGATAG 
372 
Dengue 4 FW:GACCAAAGGCAAGAGAGCACT         
RV:GCATCTGGCTTTCCAGCACT 
434 
Chikungunya FW: ACCGAATGACCATGCYAATGCTAGAG 
RV: ACAGCACACGGTCGCACGGT 
623 62 
Zika FW: ATGATACTGTTGATTGCCCC 
RV:TTCAGGCGACATTTCAAGTG 
911 53 
Mayaro Mayv1FW: GCATTCTCGCATCTGGCTAC Mayv2RV: 
GGAAGTACAAAGAAGTCGGTGC 
370 56 
Caption: FW: primer sense. RV: primer antisense. * temperature in degrees Celsius. 
Table 2. Distribution of the sociodemographic variables from patients positive by the one-step RT-PCR 
assays 
 
Number of days after the onset 
of clinical signs and symptoms 
Molecular method ELISA IgM  
p value  
Positive 
 
Negative 
 
Positive 
 
Negative 
 
Chikungunya detection 
     
1 to 3 days 185 0 140 45 p<0.0001 
4 to 6 days 113 0 94 19 p<0.0001 
7 to10 days 32 234 263  3 p<0.0001 
 
Dengue detection 
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1 to 3 days 28 0 15 13 p<0.0001 
4 to 6 days 24 0 21 3 p<0.0001 
7 to 10 days 3 0 2 1 p=0.117 
Mayaro detection      
1 to 6 days 1 0 0 1 p=0.317 
Caption: From 1 to 6 days: the acute phase, and from 7 to 10 days convalescent period. 
Table 3. Comparison of the results of the one-step RT-PCR concerning IgM-ELISA assays for acute and 
convalescent phases of the disease 
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